GenSight Biologics
gene therapy retinal diseases
- B2B
About GenSight Biologics
development of gene therapies using mitochondrial targeting and optogenetics to treat neurodegenerative retinal diseases and restore vision
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- paris, Île-de-France, France
- Founded
- 2013
- Revenue
- €1KFY2025, filed accounts, INPI
- Website
- gensight-biologics.com
GenSight Biologics at a glance
GenSight Biologics is a B2B company in the Biotechnology Research industry, headquartered in paris, Île-de-France, France.
GenSight Biologics was founded in 2013.
GenSight Biologics has 11–50 employees.
GenSight Biologics's revenue is €1K (FY2025, filed accounts, INPI).
Frequently asked questions about GenSight Biologics
What is GenSight Biologics's revenue?
GenSight Biologics's revenue is €1K (FY2025, filed accounts, INPI).
How many employees does GenSight Biologics have?
GenSight Biologics has 11–50 employees.
Where is GenSight Biologics headquartered?
GenSight Biologics is headquartered in paris, Île-de-France, France.
Selling to companies like GenSight Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies